These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18625111)

  • 1. When good cholesterol turns bad: the evolving saga of CETP inhibitors and clinical strategies to elevate high-density lipoprotein.
    Oram JF; Heinecke JW
    Curr Diab Rep; 2008 Jun; 8(3):165-7. PubMed ID: 18625111
    [No Abstract]   [Full Text] [Related]  

  • 2. When good cholesterol turns bad: the evolving saga of CETP inhibitors and clinical strategies to elevate high-density lipoprotein.
    Oram JF; Heinecke JW
    Curr Atheroscler Rep; 2007 Dec; 9(6):425-7. PubMed ID: 18377780
    [No Abstract]   [Full Text] [Related]  

  • 3. Elevated CETP activity improves plasma cholesterol efflux capacity from human macrophages in women.
    Villard EF; El Khoury P; Duchene E; Bonnefont-Rousselot D; Clement K; Bruckert E; Bittar R; Le Goff W; Guerin M
    Arterioscler Thromb Vasc Biol; 2012 Oct; 32(10):2341-9. PubMed ID: 22904275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis.
    Tall AR; Yvan-Charvet L; Terasaka N; Pagler T; Wang N
    Cell Metab; 2008 May; 7(5):365-75. PubMed ID: 18460328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-density lipoprotein extinguishes fire in fat.
    Wang N
    Circ Res; 2013 May; 112(10):1304-6. PubMed ID: 23661709
    [No Abstract]   [Full Text] [Related]  

  • 6. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins.
    Wang N; Lan D; Chen W; Matsuura F; Tall AR
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9774-9. PubMed ID: 15210959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of cholesteryl ester transfer protein overexpression and inhibition on reverse cholesterol transport.
    Tchoua U; D'Souza W; Mukhamedova N; Blum D; Niesor E; Mizrahi J; Maugeais C; Sviridov D
    Cardiovasc Res; 2008 Mar; 77(4):732-9. PubMed ID: 18056760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are human CETP mutations and CETP-inhibiting drugs a good or a bad deal?
    Luft FC
    J Mol Med (Berl); 2006 Aug; 84(8):625-7. PubMed ID: 16855847
    [No Abstract]   [Full Text] [Related]  

  • 9. ABCA1: at the nexus of cholesterol, HDL and atherosclerosis.
    Attie AD
    Trends Biochem Sci; 2007 Apr; 32(4):172-9. PubMed ID: 17324574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a role of CETP in HDL remodeling and cholesterol efflux: role of cysteine 13 of CETP.
    Maugeais C; Perez A; von der Mark E; Magg C; Pflieger P; Niesor EJ
    Biochim Biophys Acta; 2013 Nov; 1831(11):1644-50. PubMed ID: 23872476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate-limiting factors of cholesterol efflux in reverse cholesterol transport: acceptors and donors.
    Fu Y
    Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):703-9. PubMed ID: 20374257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherosclerosis: cell biology and lipoproteins.
    Daugherty A; Rateri DL
    Curr Opin Lipidol; 2008 Jun; 19(3):328-9. PubMed ID: 18460928
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel therapies to increase apolipoprotein AI and HDL for the treatment of atherosclerosis.
    Wong NC
    Curr Opin Investig Drugs; 2007 Sep; 8(9):718-28. PubMed ID: 17729183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of genetic variants in ATP-binding cassette A1 and cholesteryl ester transfer protein and differences in lipoprotein subclasses in the multi-ethnic study of atherosclerosis.
    Tsai MY; Li N; Sharrett AR; Shea S; Jacobs DR; Tracy R; Arnett D; Arends V; Post W
    Clin Chem; 2009 Mar; 55(3):481-8. PubMed ID: 19131637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of high-density lipoprotein cholesterol metabolism and reverse cholesterol transport.
    Hersberger M; von Eckardstein A
    Handb Exp Pharmacol; 2005; (170):537-61. PubMed ID: 16596814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesteryl ester transfer protein: An enigmatic pharmacology - Antagonists and agonists.
    Yamashita S; Ruscica M; Macchi C; Corsini A; Matsuzawa Y; Sirtori CR
    Atherosclerosis; 2018 Nov; 278():286-298. PubMed ID: 30347344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein.
    Favari E; Lee M; Calabresi L; Franceschini G; Zimetti F; Bernini F; Kovanen PT
    J Biol Chem; 2004 Mar; 279(11):9930-6. PubMed ID: 14701812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
    Westerterp M; van der Hoogt CC; de Haan W; Offerman EH; Dallinga-Thie GM; Jukema JW; Havekes LM; Rensen PC
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2552-9. PubMed ID: 16946130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the cholesteryl ester transfer protein inhibitor, TA-8995, on cholesterol efflux capacity and high-density lipoprotein particle subclasses.
    van Capelleveen JC; Kastelein JJ; Zwinderman AH; van Deventer SJ; Collins HL; Adelman SJ; Round P; Ford J; Rader DJ; Hovingh GK
    J Clin Lipidol; 2016; 10(5):1137-1144.e3. PubMed ID: 27678430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein A-I but not high-density lipoproteins are internalised by RAW macrophages: roles of ATP-binding cassette transporter A1 and scavenger receptor BI.
    Lorenzi I; von Eckardstein A; Cavelier C; Radosavljevic S; Rohrer L
    J Mol Med (Berl); 2008 Feb; 86(2):171-83. PubMed ID: 17906976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.